Sorry - There were no pages found that contain that search phrase.
 |
|
|
|
|
|
Treatment |
|
Location |
|
Last Updated |
|
|
|
Details |
|
Effect of NovoTTF-100A in Recurrent GBM |
|
Chicago, IL USA |
|
07/12/2008 |
|
|
|
|
|
Details |
|
Effect of NovoTTF-100A in Recurrent GBM |
|
Chicago, IL |
|
07/12/2008 |
|
|
|
Details |
|
Effect of NovoTTF-100A in Recurrent GBM |
|
Evanston, IL USA |
|
07/12/2008 |
|
|
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Chicago, IL USA |
|
07/03/2008 |
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Chicago, IL USA |
|
07/03/2008 |
|
|
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Evanston, IL USA |
|
07/03/2008 |
|
|
|
Details |
|
A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients with Recurrent High-Grade Glioma |
|
Chicago, IL USA |
|
06/28/2008 |
|
|
|
|
|
Details |
|
A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients with Recurrent High-Grade Glioma |
|
Chicago, IL USA |
|
06/28/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Maywood, IL USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Harvey, IL USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Chicago, IL USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme |
|
Harvey, IL USA |
|
04/11/2008 |
|
|
|
Details |
|
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
|
Chicago, IL USA |
|
03/01/2008 |
|
|
|
|
|
Details |
|
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
|
Evanston, IL USA |
|
03/01/2008 |
|
|
|
Details |
|
A Phase II Safety Study of Bevacizumab in Patients With Multiple Recurrent or Progressive Malignant Gliomas |
|
Chicago, IL USA |
|
08/20/2007 |
|
|
|
|
|
Details |
|
A Pilot Multicenter Phase I/II Trial of RAD001 in Patients With Recurrent Glioblastoma Multiforme |
|
Chicago, IL USA |
|
08/19/2007 |
|
|
|
Details |
|
A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel® in Subjects With Recurrent Glioma |
|
Chicago, IL USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labelled Chlorotoxin In Patients with Recurrent or Refractory Somatic and/or Cereberal Metastatic Solid Tumors |
|
Chicago, IL USA |
|
06/04/2007 |
|
|
|
Details |
|
Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination With Lapatinib in Adult Patients With Relapsed Malignant Glioma |
|
Chicago, IL USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Harvey, IL USA |
|
05/01/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Chicago, IL USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Park Ridge, IL USA |
|
04/29/2007 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Park Ridge, IL USA |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Chicago, IL USA |
|
10/12/2006 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Chicago, IL USA |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
|
Urbana, IL USA |
|
06/26/2006 |
|
|
|
Details |
|
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
|
Peoria, IL USA |
|
06/26/2006 |
|
|
|
|
|
Details |
|
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
|
Moline, IL USA |
|
06/26/2006 |
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Urbana, IL USA |
|
06/26/2006 |
|
|
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Peoria, IL USA |
|
06/26/2006 |
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Moline, IL USA |
|
06/26/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Chicago, IL USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Peoria, IL USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors |
|
Chicago, IL USA |
|
05/27/2006 |
|
|
|
Details |
|
Phase II Study of Pemetrexed Disodium (Alimta) in Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases |
|
Chicago, IL USA |
|
05/01/2006 |
|
|
|
|
|
Details |
|
Phase II Study Evaluating the Efficacy of Imatinib Mesylate (Gleevec) in Combination With Hydroxyurea in Patients With Recurrent Glioblastoma Multiforme (GBM) Receiving Enzyme-Inducing Anticonvulsant Drugs |
|
Chicago, IL USA |
|
05/01/2006 |
|
|
|
Details |
|
Phase II Study of O6-Benzylguanine and Temozolomide (Temodar) in Pediatric Patients With Recurrent or Progressive High-Grade Gliomas or Brain Stem Tumors |
|
Chicago, IL USA |
|
05/01/2006 |
|
|
|
|
|
Details |
|
Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery |
|
Chicago, IL USA |
|
04/30/2006 |
|
|
|
Details |
|
Efficacy and Safety of Imatinib Mesylate (Gleevec) Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)
|
|
Chicago, IL USA |
|
04/30/2006 |
|
|
|
|
|
Details |
|
A Phase I/II Trial of PEG-Interferon Alfa-2B (PEG-Intron)
for Plexiform Neurofibromas (NF1 patients) |
|
Chicago, IL USA |
|
12/04/2005 |
|
|
|
Details |
|
Tipifarnib and Radiation Therapy in Treating Young Patients with Brainstem Glioma |
|
Chicago, IL USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
A Phase I/II Study of Reirradiation for Recurrent Pediatric Brain and Spinal Cord Tumors and Primary Glioblastoma Multiforme Using the Photon Radiosurgery System |
|
Chicago, IL USA |
|
11/27/2005 |
|
|
|
Details |
|
Phase II Prospective Study of Sequential Myeloablative Chemotherapy with Stem Cell Rescue for the Treatment of Selected High Risk CNS Tumors and Recurrent CNS Tumors. |
|
Chicago, IL USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
|
Urbana, IL USA |
|
11/27/2005 |
|
|
|
Details |
|
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
|
Peoria, IL USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
|
Moline, IL USA |
|
11/27/2005 |
|
|
|
Details |
|
Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas |
|
Chicago, IL USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Oak Lawn, IL USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Chicago, IL USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Park Ridge, IL USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Chicago, IL USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Peoria, IL USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Springfield, IL USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Chicago, IL USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Chicago, IL USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
A Phase I, Molecular Biology, and Phase II Study of Lapatinib (GW572016) in Pediatric Patients with Recurrent or Refractory Medulloblastoma, Malignant Glioma or Ependymoma
|
|
Chicago, IL USA |
|
11/27/2005 |
|
|
|
Details |
|
Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors
|
|
Chicago, IL USA |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors
|
|
Springfield, IL USA |
|
11/26/2005 |
|
|
|
Details |
|
Frameless Computer Assisted Stereotactic Surgery for Resection of Brain Tumors in Adults and Children |
|
Rockford, IL USA |
|
11/25/2005 |
|
|
|
|
|
Details |
|
Frameless Computer Guided Stereotactic Sugery for Resection of Brain Tumors in Adults and Children |
|
Rockford, IL USA |
|
11/25/2005 |
|
|
|
Details |
|
A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma |
|
Chicago, IL |
|
11/13/2005 |
|
|
|
|
|
Details |
|
Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
|
|
Chicago, IL USA |
|
11/11/2005 |
|
|
|
Details |
|
VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors |
|
Chicago, IL USA |
|
11/11/2005 |
|
|
|
|
|
Details |
|
Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases |
|
Decatur, IL USA |
|
11/06/2005 |
|
|
|
Details |
|
Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases |
|
Chicago, IL USA |
|
11/06/2005 |
|
|
|
|
|
Details |
|
A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy |
|
Decatur, IL USA |
|
11/06/2005 |
|
|
|
Details |
|
A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy |
|
Urbana, IL USA |
|
11/06/2005 |
|
|
|
|
|
Details |
|
A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy |
|
Moline, IL USA |
|
11/06/2005 |
|
|
|
